​

Inovio Pharmaceuticals (INO) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

INO Stock Forecast

Inovio Pharmaceuticals (INO) stock forecast, based on 4 Wall Street analysts, predicts a 12-month average price target of $8.00, with a high of $8.00 and a low of $8.00. This represents a 294.09% increase from the last price of $2.03.

- $3 $6 $9 $12 $15 High: $8 Avg: $8 Low: $8 Last Closed Price: $2.03

INO Stock Rating

Inovio Pharmaceuticals stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 2 Buy (50.00%), 2 Hold (50.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 2 2 Strong Sell Sell Hold Buy Strong Buy

INO Forecast vs Benchmarks

TypeNameUpside
StockInovio Pharmaceuticals294.09%
SectorHealthcare Stocks 25.20%
IndustryBiotech Stocks 63.35%

Price Target Trends

1M3M12M
# Anlaysts--3
Avg Price Target--$22.67
Last Closing Price$2.03$2.03$2.03
Upside/Downside--1016.75%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 25123--6
Dec, 24123--6
Nov, 24243--9
Oct, 24243--9
Sep, 24243--9
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 09, 2024Gregory RenzaRBC Capital$8.00$8.71-8.15%294.09%
May 14, 2024Hartaj SinghOppenheimer$40.00$11.45249.34%1870.44%
May 13, 2024Sudan LoganathanStephens$20.00$11.3676.06%885.22%
Jan 25, 2024Hartaj SinghOppenheimer$4.00$6.79-41.09%97.04%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Nov 18, 2024OppenheimerOutperformOutperformhold
Oct 04, 2024OppenheimerUnderperformUnderperformhold
Aug 09, 2024RBC CapitalSector PerformSector Performhold
May 14, 2024OppenheimerOutperformOutperformhold
May 14, 2024H.C. WainwrightNeutralNeutralhold
May 13, 2024StephensOverweightinitialise
Jan 25, 2024OppenheimerOutperformupgrade

Financial Forecast

EPS Forecast

$-30 $-23 $-16 $-9 $-2 $5 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.39$-1.46$-1.21$-6.09-----
Avg Forecast$-13.82$-15.00$-13.30$-6.10$-4.21$-2.92$-2.10$-1.57$-0.54
High Forecast$-24.21$-26.29$-29.98$-6.77$-4.49$-4.08$-3.41$-2.62$-1.22
Low Forecast$-3.42$-3.71$3.33$-5.35$-4.00$-1.75$-1.25$-0.34$0.14
Surprise %-89.94%-90.27%-90.90%-0.16%-----

Revenue Forecast

$0 $170M $340M $510M $680M $850M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$7.41M$1.77M$10.26M$832.01M-----
Avg Forecast$3.21M$3.33M$10.55M$1.06M$133.50K$3.12M$26.55M$78.50M$139.20M
High Forecast$1.35M$1.40M$404.28K$824.44K$111.25K$80.99K$26.54M$77.86M$3.62M
Low Forecast$5.07M$5.27M$20.74M$1.18M$166.88K$6.15M$26.56M$79.13M$274.60M
Surprise %130.77%-46.78%-2.75%78391.51%-----

Net Income Forecast

$-150B $-110B $-70B $-30B $10B $50B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-215.09M$-305.38M$-287.66M$-135.12B-----
Avg Forecast$-306.33M$-332.61M$-294.82M$-135.12M$-94.16M$-64.62M$-51.66M$-56.67M$-11.97M
High Forecast$-536.88M$-582.94M$-664.82M$-150.14M$-99.66M$-90.44M$-75.61M$-58.15M$-27.12M
Low Forecast$-75.78M$-82.28M$73.76M$-118.53M$-88.66M$-38.79M$-27.72M$-7.55M$3.19M
Surprise %-29.79%-8.18%-2.43%99900.00%-----

INO Forecast FAQ

Is Inovio Pharmaceuticals stock a buy?

Inovio Pharmaceuticals stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 2 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Inovio Pharmaceuticals is a favorable investment for most analysts.

What is Inovio Pharmaceuticals's price target?

Inovio Pharmaceuticals's price target, set by 4 Wall Street analysts, averages $8 over the next 12 months. The price target range spans from $8 at the low end to $8 at the high end, suggesting a potential 294.09% change from the previous close price of $2.03.

How does Inovio Pharmaceuticals stock forecast compare to the average forecast of its sector, industry, and investment themes?

Inovio Pharmaceuticals stock forecast shows a 294.09% upside, outperforming the average forecast for the healthcare stocks sector (25.20%) and outperforming the biotech stocks industry (63.35%).

What is the breakdown of analyst ratings for Inovio Pharmaceuticals over the past three months?

  • January 2025: 16.67% Strong Buy, 33.33% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 16.67% Strong Buy, 33.33% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.
  • November 2024: 22.22% Strong Buy, 44.44% Buy, 33.33% Hold, 0% Sell, 0% Strong Sell.

What is Inovio Pharmaceuticals’s EPS forecast?

Inovio Pharmaceuticals's average annual EPS forecast for its fiscal year ending in December is -4.21 for 2024, a -30.87% decrease from the reported $-6.09 in 2023. The prediction for 2025 is $-2.92, $-2.1 for 2026, $-1.57 for 2027, and $-0.54 for 2028.

What is Inovio Pharmaceuticals’s revenue forecast?

Inovio Pharmaceuticals's average annual revenue forecast for its fiscal year ending in December is $133.5K for 2024, a -99.98% decrease from the reported $832.01M in 2023. The forecast for 2025 is $3.12M, $26.55M for 2026, $78.5M for 2027, and $139.2M for 2028.

What is Inovio Pharmaceuticals’s net income forecast?

For its fiscal year ending in December, Inovio Pharmaceuticals's average annual net income forecast is $-94.161M for 2024, reflecting a -99.93% decrease from the reported $-135B in 2023. The projection for 2025 is $-64.616M, $-51.665M for 2026, $-56.675M for 2027, and $-11.974M for 2028.